Live Cell Imaging Market Share Value, Growth Insights, Future Trends and Regional Outlook By 2023

Live Cell Imaging Market Size, Trends and Growth Analysis By Products (Equipment, Consumables, Software), Technology (Fluorescence Recovery After Photobleaching (FRAP), Others), Application (Drug Discovery, Cell Biology, Others), End-User – Global Forecast Till 2023

Live Cell Imaging Market Overview

According to Market Research Future (MRFR), the global live cell imaging market is estimated to amass significant market value, thriving at a CAGR of 9% during the forecast period from 2018 to 2023.

The increasing prevalence of chronic illness such as cancer has demanded quicker and efficient diagnostic methods, which is estimated to be the key driver of the live cell imaging market 2020. The growing applications of live cell imaging in the biotech and pharmaceutical industry are expected to enhance the demand and develop the market. In addition, it can also be used to study protein trafficking and enzyme activity which can augment the market.  Furthermore, the surging approvals from regulatory bodies are predicted to underpin the market growth by increasing its demand.

Request Free Sample Copy of the report “ Live Cell Imaging Market Research Report – Forecast to 2023″ at: https://www.marketresearchfuture.com/sample_request/6075

However, the cost of implementation live cell imaging is very high, which can impede the market growth. Besides, the lack of skilled professionals to understand cell functions is also expected to restrict the market growth. Nonetheless, the growing funds and investments in training and development programs are anticipated to counter the hampering factors and grow the market.

Live Cell Imaging Market Segmentation

The segment analysis of the global live cell imaging market is done by technology, products, end-user, and application.

The technology-based segments of the global live cell imaging market are multiphoton excitation microscopy, fluorescence recovery after photobleaching, fluorescence resonance energy transfer, high-content analysis, fluorescence in situ hybridization, ratiometric imaging, total internal reflection fluorescence microscopy, and other technologies.

The products-based segments of the global live cell imaging market are consumables, equipment, and software. The equipment is further segmented into standalone systems, microscopes, cell analyzer, and image-capturing devices. The microscopes are sub-segmented as confocal microscopes, conventional microscopes, and advanced fluorescence microscopes. The consumables are sub-segmented into reagents, assay kits, media, and others.

The end-user based segments of the global live cell imaging market are diagnostic laboratories, biotechnology companies, pharmaceutical companies, hospitals, and others.

The application-based segments of the global live cell imaging market are stem cells, cell biology, developmental biology, and drug discovery.

Live Cell Imaging Market Regional Analysis

Based on the region, the global live cell imaging market is segmented into Europe, North America, Asia-Pacific, and the Rest of the World (RoW).

As per the analysis, North America is likely to dominate the global live cell imaging market owing to the substantial investments into research and development programs. Further, the presence of advanced healthcare infrastructure is predicted to boost the regional market during the evaluation period.

Europe is predicted to acquire the second position during the review period owing to the aid provided by governments of various nations. Further, the growing prevalence of chronic illness in the region is expected to strengthen the regional market.

The APAC market is expected to emerge as a lucrative market during the forecast period. The developing countries such as India, Japan, and China are likely to make a crucial contribution in developing the regional market. Japan is anticipated to be the largest market for live cell imaging owing to the growing cancer cases. On the other hand, China is expected to prosper due to the availability of low-cost diagnostic methods.

The MEA region is expected to acquire the least market share due to lack of technical knowledge and poor medical facilities.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/live-cell-imaging-market-6075

Live Cell Imaging Market Key Players

Some of the renowned players of the global live cell imaging market are Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, GE Healthcare (U.K.), LCC (U.S.), PerkinElmer, Inc. (U.S.), Dickinson and Company (U.S.), Becton, Danaher Corporation (U.S.), BioTek Instruments (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

Browse More Healthcare Related Research Report at:

Peripheral Artery Disease Market is poised to mature at a CAGR of 4.84% to reach USD 23.62 billion by 2025

Cancer Biomarkers Market size is projected to grow at a healthy CAGR by 2023

Mammography Market size is set to expand at a CAGR of 7.16% over the forecast period

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com